Glycans in Medicinal Chemistry
作者： A. Lacetera , S. Galante , J. Jiménez-Barbero , S. Martín-Santamaría
DOI: 10.1016/B978-0-12-409547-2.11712-3
关键词:
摘要: This article focuses on the applications of carbohydrate molecules in medicinal and pharmaceutical chemistry. Particular emphasis has been paid to these glycans that are currently used market with different properties. In particular, we have highlighted role cancer, metabolic diseases, or immune response, also emphasizing those display properties as antibiotics, antifungals, antivirals, anticoagulants, well their use therapeutics, either alone conjugated glycoproteins.
sci-hub.st 参考文章(157)
Lai-Xi Wang, Paolo Costantino, Yu Geng, Hong Zhang, Anti-Carbohydrate HIV Vaccine Design Springer, New York, NY. pp. 143- 176 ,(2014) , 10.1007/978-1-4614-8872-9_6
Francesco Peri, Valentina Calabrese, Toll-like Receptor 4 (TLR4) Modulation by Synthetic and Natural Compounds: An Update Journal of Medicinal Chemistry. ,vol. 57, pp. 3612- 3622 ,(2014) , 10.1021/JM401006S
Jaroslav Spížek, Jitka Novotná, Tomáš Řezanka, Lincosamides: Chemical Structure, Biosynthesis, Mechanism of Action, Resistance, and Applications Advances in Applied Microbiology. ,vol. 56, pp. 121- 154 ,(2004) , 10.1016/S0065-2164(04)56004-5
K. O. François, J. Balzarini, Potential of carbohydrate-binding agents as therapeutics against enveloped viruses. Medicinal Research Reviews. ,vol. 32, pp. 349- 387 ,(2012) , 10.1002/MED.20216
A. Poltorak, Bruce A Beutler, Positional cloning of Lps, and the general role of toll-like receptors in the innate immune response. European Cytokine Network. ,vol. 11, pp. 143- 152 ,(2000)
André Scheen, Clinical efficacy of acarbose in diabetes mellitus: a critical review of controlled trials. Diabetes & Metabolism. ,vol. 24, pp. 311- 320 ,(1998)
F M Apter, P Michetti, L S Winner, J A Mack, J J Mekalanos, M R Neutra, Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo. Infection and Immunity. ,vol. 61, pp. 5279- 5285 ,(1993) , 10.1128/IAI.61.12.5279-5285.1993
Vanessa Leiria Campo, Valquiria Aragão-Leoneti, Ivone Carvalho, Glycosidases and diabetes: metabolic changes, mode of action and therapeutic perspectives pp. 181- 203 ,(2013) , 10.1039/9781849737173-00181
G. Ada, D. Isaacs, Carbohydrate—protein conjugate vaccines Clinical Microbiology and Infection. ,vol. 9, pp. 79- 85 ,(2003) , 10.1046/J.1469-0691.2003.00530.X
Vince Pozsgay, Recent developments in synthetic oligosaccharide-based bacterial vaccines. Current Topics in Medicinal Chemistry. ,vol. 8, pp. 126- 140 ,(2008) , 10.2174/156802608783378864